{"podcast":{"title":"Safe Doesn't Scale","slug":"safe-doesn-t-scale-7693846","podcast_index_feed_id":7693846,"rss_url":"https://feeds.captivate.fm/limelight/","website_url":"https://www.limelighthq.com/","image_url":"https://artwork.captivate.fm/acfbba0c-a85e-4aa3-9cd2-d33855c85dcd/SDS-Artwork.jpg","author":"David Walsh","episode_count":20,"summary":"\"What's the ROI?\" Those three words kill more creative marketing ideas than bad execution ever will. Not here. Safe Doesn't Scale is a weekly podcast for marketing and growth leaders. We’ll be interviewing Heads of Marketing, Unicorn Founders, and Revenue Leaders at B2B companies to prove that the riskiest marketing campaigns drive the biggest returns. While brands are burning $500K on LinkedIn ads that are generating zero demos, there’s someone out there who closed a $2M deal they sourced from a meme. Host David Walsh, Founder of Limelight, breaks down real examples from brands spending less and converting more by leaning into creator-led growth, unconventional distribution, and campaigns that make traditional marketers panic. You’ll learn: How growth leaders sell “unsafe” ideas to the C-suite How to attribute sales pipeline to content, creators, and social signals Why the campaigns that feel uncomfortable often drive the most revenue No e-book downloads. No buzzwords. This show is for marketers with a chip on their shoulder who are tired of playing it safe. We celebrate the campaigns that make legal sweat and sales teams crush quota. Because marketers who don't take risks won't…","last_synced_at":"2026-07-09T16:20:37.514205+00:00","page_url":"https://stenobird.com/podcast/safe-doesn-t-scale-7693846"},"episode":{"title":"Everyone's Obsessed With the Wrong Thing in AI Marketing (with Megan Bowen from Refine Labs) | Ep. 17","slug":"everyone-s-obsessed-with-the-wrong-thing-in-ai-marketing-with-megan-bowen-from-refine-labs-ep-17","published_at":"2026-06-25T07:00:00+00:00","page_url":"https://stenobird.com/podcast/safe-doesn-t-scale-7693846/everyone-s-obsessed-with-the-wrong-thing-in-ai-marketing-with-megan-bowen-from-refine-labs-ep-17","show_page_url":"https://stenobird.com/podcast/safe-doesn-t-scale-7693846","url":"https://www.limelighthq.com/","audio_url":"https://episodes.captivate.fm/episode/c5ecffed-91c9-452d-ab61-b9ad47bf405c.mp3","summary":"Every marketing team is being told that if they haven't shipped an AI agent this quarter, they're behind. The irony is that the companies winning in the AI era are the ones doing the unglamorous work: clear positioning, real brand investment, messaging that actually says something. The tools changed. What gets you discovered didn't. ㅤ On this episode of Safe Doesn't Scale, David Walsh of Limelight sits down with Megan Bowen , CEO of Refine Labs , to talk about what's actually changed for B2B buyers now that ChatGPT and Claude are part of how they research solutions. They cover positioning, brand measurement, and where AI belongs in a go-to-market strategy. You'll leave with a sharper sense of what to fix before you automate anything. ㅤ Megan spent her career on the operating side of B2B growth before taking over Refine Labs, and she brings receipts. She walks through a controlled LinkedIn experiment that produced 60% more qualified pipeline, why most Google Ads budgets quietly leak money, and the hard lesson Refine Labs learned when it leaned too heavily on a single founder brand. ㅤ Guest Bio Megan Bowen is the CEO of Refine Labs, the B2B marketing agency she helped scale before stepping into the top role. Refine Labs launched in 2019 and has worked with more than 300 B2B SaaS and tech companies, driving qualified pipeline through demand strategy, paid media, and content production. Her background runs through customer success and operations leadership at companies like Grubhub and Managed by Q, which is why she treats marketing as a business function rather than a list of tactics. She's become one of the clearer voices arguing that AI raises the value of marketing fundamentals instead of replacing them. ㅤ What We Cover How AI changed buyer behavior: Buyers now researc…","meta_description":"Every marketing team is being told that if they haven't shipped an AI agent this quarter, they're behind. The irony is that the companies winning in the A…","key_points":[],"chapters":[],"topics":[],"duration_seconds":1768,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/safe-doesn-t-scale-7693846/episodes/everyone-s-obsessed-with-the-wrong-thing-in-ai-marketing-with-megan-bowen-from-refine-labs-ep-17/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/safe-doesn-t-scale-7693846/everyone-s-obsessed-with-the-wrong-thing-in-ai-marketing-with-megan-bowen-from-refine-labs-ep-17.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}